Beim Global participates in 'Imkas 2025'

Byme Global, a subsidiary of Byme, announced that it participated in the 'IMCAS 2025', an international conference for aesthetic surgery, for the fourth consecutive year. The event was held at the Palais des Congrès de Paris, France from January 30 to February 2, and Byme Global promoted the excellence of its 'Juvelook' and 'Juvelook Volume (overseas product name: Renisna)' products.

IMCAS is an international conference where medical professionals and aesthetic medicine professionals from around the world gather to share the latest academic information and technology trends. This year, it was held with approximately 24,000 professionals in attendance. Vim Global has participated every year since 2022, and at this event, it held a separate symposium to share research on the effect of volume increase through subcutaneous fat layer injection of Juvelook Volume.

More than 300 people attended this symposium, which was held in the last session of the event. Byim Global also strengthened its global network through booth exhibitions and meetings with overseas buyers and corporate officials, and continued to find additional business partners and promote to countries that have not been used.

A representative of Vime Global said, “We will continue to participate in global academic conferences to increase our brand awareness.”


  • See more related articles